...new collaboration with Icahn School of Medicine to investigate triggers of inflammatory bowel disease (IBD) Latitude Pharmaceuticals Inc./Xeris...

...JDRF and Xeris declined to disclose details, and Latitude could not be reached for comment. Latitude Pharmaceuticals Inc....

...release of small molecule and biological therapeutics via a phospholipid gel. Financial terms are undisclosed. Latitude Pharmaceuticals Inc....